星亞控股(08293.HK)與石墨烯紅外睡眠床墊生產商就合作訂諒解備忘
星亞控股(08293.HK)公布,集團與潛在夥伴浙江康烯新材料科技訂立無法律約束力的諒解備忘錄,對方在中國生產和銷售石墨烯紅外睡眠床墊及石墨烯應用發熱膜給予醫療保健行業。
雙方正在討論潛在合作形式,可能包括集團及潛在夥伴成立合營企業;或集團投資潛在夥伴。於討論結束後,各方將簽署正式協議,條款計有集團將負責提供人力資源支援。潛在夥伴將負責生產和銷售石墨烯紅外睡眠床墊及石墨烯應用發熱膜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.